Albany NY, United States: Interventional neurology can be defined as a specialty aimed at treating major diseases of the brain, spine, and neck, through minimally invasive image guided techniques.
Albany NY, United States: Interventional neurology can be defined as a specialty aimed at treating major diseases of the brain, spine, and neck, through minimally invasive image guided techniques. Major diseases treated by interventional neurologists include cerebral aneurysm, head and neck tumors, intracranial atherosclerosis, meningiomas, ischemic strokes, spinal vascular malformations, and vertebral body tumors. Intracranial aneurysm, such as subarachnoid hemorrhage, is one of the common neurological disease affecting over 30,000 people in the U.S. each year and over 2% of the global population. Central nervous system arteriovenous malformations (AVMs) have been reported in over 0.15% of the U.S. population, of which over 90% are supratentorial located. Among these, over 4% of the cerebral AVMs are due to hemorrhagic conversions.
Read Report Overview - https://www.transparencymarketresearch.com/interventional-neurology-market.html
Significant rise in the prevalence of neurological diseases, severity of the disease, rising demand for effective treatment methods, surge in demand for minimally invasive procedures, and growing awareness among people is expected to contribute to the growth of the market. In addition, technological advancements in the field of interventional neurology, rising patient pool of hemorrhagic and ischemic stroke, and strong focus on research & development leading to new product launches and product enhancements, are anticipated to fuel the growth of the market. Moreover, decreasing cost of products attributed to the strengthening of the distribution networks and localized manufacturing is likely to boost market growth during the forecast period. However, dearth of trained interventional neurologists and stringent regulatory procedures, among others are anticipated to hamper market growth. Furthermore, high cost of procedures, lack of disposable income in the developing regions, and the lack of well-established reimbursement policies are expected to restrain the market during the forecast period.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30674
The global interventional neurology market can be segmented based on product type, indication, end-user, and region. In terms of product type, the market can be segmented into coiling and embolization devices, angioplasty and stenting systems, support devices, and neurothrombectomy devices. The coiling and embolization devices segment can be sub-segmented into embolic coils, liquid embolic agents, and flow diverting devices. The angioplasty and stenting systems segment can be bifurcated into carotid artery stents and embolic protection systems. Support devices include microcatheters and guidewires. Based on indication, the market can be categorized into cerebral aneurysms, ischemic stroke, arteriovenous malformations, and others. In terms of end-user, the market can be segmented into hospitals, ambulatory surgical centers, clinics, and others.
Request for Analysis of COVID-19 Impact on Interventional Neurology Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30674
Geographically, the global interventional neurology market can be segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the market in terms of revenue in 2016. It is anticipated to continue to dominate the market during the forecast period. Strong growth in the region can be attributed to the well-established health care infrastructure, growing awareness among people, and strong focus on research & development. Europe is anticipated to be the second largest market in terms of revenue. Asia Pacific is anticipated to expand at a significantly high CAGR during the forecast period, with growth being driven by China and India. Growth in these countries is driven by increasing patient population, government focus on enhancing health care infrastructure, and rising awareness among people.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=30674
Leading players in the global interventional neurology market include Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Penumbra, Inc., Merit Medical Systems, Inc., MicroPort Scientific Corporation, W. L. Gore & Associates, Inc., and Cook Medical. The primary growth strategies adopted by the market players include acquisitions, partnerships, collaborations, product launches, and product enhancements, to strengthen their position in the market.
Pre Book Interventional Neurology Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=30674<ype=S
More Trending Reports by Transparency Market Research:
Performance-enhancing Drugs Market Performance-enhancing drugs are substances intended to improve performance in athletic activities. Muscle development and increase in oxygen-carrying capacity of the blood are a few of the important impacts instigated by the utilization of performance-enhancing drugs. As per the Health Research Funding, in 2015, approximately 1,084,000 people in North America were found to include performance-enhancing drugs in their daily routine for some reason.
Plasma Component Separator Market Increase in per capita income and changing lifestyles (especially food habits) have resulted into rise in prevalence of diabetes, heart attack/stroke, cancer, and other life threatening diseases. Component in the blood are used to treat these blood related diseases. Presently, when blood is donated, it is separated into three component: plasma, red blood cells, and platelets. Plasma are generally used to increase blood volume or it can be separated into individual plasma proteins such as fibrinogen, factor VIII, anti-thrombin III, and factor IX.
Thoracolumbar Spine Devices Market Thoracolumbar spine refers to the upper and middle back which joins the cervical spine. Thoracolumbar spine devices are used in spinal stabilization in pathologies such as degenerative spinal disc disease. Increasing geriatric population across the globe is expected to drive demand for thoracolumbar spine devices, with increased prevalence of diseases within this population, thus ultimately increasing the number of spinal surgeries performed.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453